Skip to main content
. 2017 Aug 10;11(2):198–203. doi: 10.1093/ckj/sfx078

Table 2.

Clinical and biochemical features in patients with aHUS associated with CD46 mutation

Patient Age, sex Features Hypertension; proteinuria Hemoglobin (g/dL; platelet/mm3) Peak creatinine (mg/dL) Serum C3 (mg/dL)a FH (mg/dL)b; antibody (AU/mL) Relapses eGFR (mL/min/1.73 m2) at follow-up
1 9 years, M Fever, oliguria Stage 2; 1+ 6.1; 670 00 5.30 131 200; 6277 1 (after 1 year) 70 after 1.5 years
2 5 years, M Dengue, melena, high transaminases Stage 2; 4+ 6.0; 80 000 5.93 99 124; 62 None 100 after 3 months; normal blood pressure
3 8 years, F Pallor, oliguria NA NA NA NA 171; <37 None 95 after 3 years; normal blood pressure
4 6 months, M Fever, diarrhea, high transaminases None 5.7; 59 000 3.20 96 151; <37 None 46 after 1 month; normal blood pressure
5 6 years, M Fever Stage 2; 2+ 9.9; 300 000 4.60 180 152; <37 NA NA
6 1.7 years, M NA NA NA NA 97 162; 85 11 (interval 0.5–2 years) 90 after 14 years
7 1.5 years, M Oliguria, high transaminases Stage 1; 4+ 5.5; 21 000 0.95 57 199; 43 1 (after 5 years) 75 after 5 years
8 10 months, F Fever, oliguria, hematuria Stage 1; 3+ 4.9; 34 000 1.42 73 200; 57 NA NA
9 3 years, M Diarrhea, pallor, oliguria None, 1+ 7.3; 161 000 4.9 45 170; 77.4 1 (after 6 months) 95 after 14 months
10 15 years, M Fever, cough, coryza Stage 1; 2+ 8.6, 80 000 8.3 136 180; 54.8 1 (after 3 years) 90 after 3 .5 years; normal blood pressure

Therapy included PD or hemodialysis; Patient 1 also received plasma exchanges and received immunosuppressive agents; Patients 2, 7, and 8 received plasma infusions.

Patients 2 and 3 (previously reported in Bhatia et al. [14]) and 7 and 8 are siblings.

AU/mL, arbitrary units/mL; eGFR, estimated glomerular filtration rate; FH, complement factor H; HD, hemodialysis; F, female; M, male; NA, not available.

a,b

Serum C3 normal range 90–130 mg/dL. b FH normal range 150–320 mg/dL.